Back
Intellia Therapeutics Vs. Merus NV Industry Stock Comparison
Sell
43
NTLA
Intellia Therapeutics
Last Price:
25.16
Seasonality Move:
23.31%
Buy
74
MRUS
Merus NV
Last Price:
56.50
Seasonality Move:
6.15%
Sell
43
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $25.15. The Score for NTLA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Merus NV (MRUS)
is a Buy
Is Merus NV a Buy, Sell or Hold?
- The current Merus NV [MRUS] share price is $56.55. The Score for MRUS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- MRUS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $25.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
MRUS Stock Price Chart
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 56.19 | Buy |
| Chaikin Money Flow: | -750740 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.81 - 25.89) | Buy |
| Bollinger Bands (100): | (22.82 - 28.4) | Sell |
MRUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.72 | Buy |
| Relative Strength Index (14 RSI): | 60.79 | Buy |
| Chaikin Money Flow: | -65155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.2 - 56.18) | Buy |
| Bollinger Bands (100): | (39.85 - 50.89) | Buy |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.09 | Buy |
| 20-day SMA: | 24.04 | Buy |
| 50-day SMA: | 23.64 | Buy |
| 200-day SMA: | 27.83 | Sell |
| 8-day EMA: | 24.48 | Buy |
| 20-day EMA: | 24.08 | Buy |
| 50-day EMA: | 24.38 | Buy |
| 200-day EMA: | 28.73 | Sell |
MRUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.05 | Buy |
| 20-day SMA: | 52.09 | Buy |
| 50-day SMA: | 47.26 | Buy |
| 200-day SMA: | 35.05 | Buy |
| 8-day EMA: | 55.4 | Buy |
| 20-day EMA: | 52.74 | Buy |
| 50-day EMA: | 48.89 | Buy |
| 200-day EMA: | 38.23 | Buy |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.00 per share, an increase this year of $0.28 per share, and a decrease next year of $0.38 per share.
Merus NV Earnings Growth & MRUS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.33 per share.
Intellia Therapeutics Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Merus NV Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||